These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 12151548

  • 1. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF.
    Tofaris GK, Patterson PH, Jessen KR, Mirsky R.
    J Neurosci; 2002 Aug 01; 22(15):6696-703. PubMed ID: 12151548
    [Abstract] [Full Text] [Related]

  • 2. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M.
    Hartner A, Goppelt-Struebe M, Hocke GM, Sterzel RB.
    Kidney Int; 1997 Jun 01; 51(6):1754-60. PubMed ID: 9186863
    [Abstract] [Full Text] [Related]

  • 3. LIF-and IL-1 beta-mediated increases in substance P receptor mRNA in axotomized, explanted or dissociated sympathetic ganglia.
    Ludlam WH, Chandross KJ, Kessler JA.
    Brain Res; 1995 Jul 10; 685(1-2):12-20. PubMed ID: 7583237
    [Abstract] [Full Text] [Related]

  • 4. Induction of LIF-mRNA by TGF-beta 1 in Schwann cells.
    Matsuoka I, Nakane A, Kurihara K.
    Brain Res; 1997 Nov 21; 776(1-2):170-80. PubMed ID: 9439810
    [Abstract] [Full Text] [Related]

  • 5. Leukemia inhibitory factor is an autocrine survival factor for Schwann cells.
    Dowsing BJ, Morrison WA, Nicola NA, Starkey GP, Bucci T, Kilpatrick TJ.
    J Neurochem; 1999 Jul 21; 73(1):96-104. PubMed ID: 10386959
    [Abstract] [Full Text] [Related]

  • 6. Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro.
    Sugiura S, Lahav R, Han J, Kou SY, Banner LR, de Pablo F, Patterson PH.
    Eur J Neurosci; 2000 Feb 21; 12(2):457-66. PubMed ID: 10712626
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activation of acidic sphingomyelinase and protein kinase C zeta is required for IL-1 induction of LIF mRNA in a Schwann cell line.
    Carlson CD, Hart RP.
    Glia; 1996 Sep 21; 18(1):49-58. PubMed ID: 8891691
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-1 beta increases leukemia inhibitory factor mRNA levels through transient stimulation of transcription rate.
    Carlson CD, Bai Y, Jonakait GM, Hart RP.
    Glia; 1996 Oct 21; 18(2):141-51. PubMed ID: 8913777
    [Abstract] [Full Text] [Related]

  • 11. Leukemia inhibitory factor, interleukin-6, and their receptors are expressed transiently in the olfactory mucosa after target ablation.
    Nan B, Getchell ML, Partin JV, Getchell TV.
    J Comp Neurol; 2001 Jun 18; 435(1):60-77. PubMed ID: 11370011
    [Abstract] [Full Text] [Related]

  • 12. Localization of leukemia inhibitory factor and interleukin-6 messenger ribonucleic acids in regenerating rat skeletal muscle.
    Kami K, Senba E.
    Muscle Nerve; 1998 Jun 18; 21(6):819-22. PubMed ID: 9585342
    [Abstract] [Full Text] [Related]

  • 13. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ, Chesnokova V, Melmed S.
    Endocrinology; 1998 May 18; 139(5):2201-8. PubMed ID: 9564823
    [Abstract] [Full Text] [Related]

  • 14. A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells.
    Shih CC, Hu MC, Hu J, Weng Y, Yazaki PJ, Medeiros J, Forman SJ.
    Blood; 2000 Mar 15; 95(6):1957-66. PubMed ID: 10706861
    [Abstract] [Full Text] [Related]

  • 15. Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation.
    Kurek JB, Austin L, Cheema SS, Bartlett PF, Murphy M.
    Neuromuscul Disord; 1996 Mar 15; 6(2):105-14. PubMed ID: 8664561
    [Abstract] [Full Text] [Related]

  • 16. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves.
    Ito Y, Yamamoto M, Li M, Doyu M, Tanaka F, Mutch T, Mitsuma T, Sobue G.
    Brain Res; 1998 May 18; 793(1-2):321-7. PubMed ID: 9630704
    [Abstract] [Full Text] [Related]

  • 17. LIF is an autocrine factor for sympathetic neurons.
    Cheng JG, Patterson PH.
    Mol Cell Neurosci; 1997 May 18; 9(5-6):372-80. PubMed ID: 9361275
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-1 involvement in the induction of leukemia inhibitory factor mRNA expression following axotomy of sympathetic ganglia.
    Carlson CD, Bai Y, Ding M, Jonakait GM, Hart RP.
    J Neuroimmunol; 1996 Nov 18; 70(2):181-90. PubMed ID: 8898726
    [Abstract] [Full Text] [Related]

  • 19. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R.
    J Neurosurg; 1998 Mar 18; 88(3):541-8. PubMed ID: 9488310
    [Abstract] [Full Text] [Related]

  • 20. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
    Ishimi Y, Abe E, Jin CH, Miyaura C, Hong MH, Oshida M, Kurosawa H, Yamaguchi Y, Tomida M, Hozumi M.
    J Cell Physiol; 1992 Jul 18; 152(1):71-8. PubMed ID: 1618924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.